Get the Stockscreener App
13.80
6.65%
0.86
Orthofix Medical Inc stock is traded at $13.80, with a volume of 746.05K.
It is up +6.65% in the last 24 hours and up +24.89% over the past month.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
See More
Previous Close:
$12.94
Open:
$13.08
24h Volume:
746.05K
Relative Volume:
1.78
Market Cap:
$545.02M
Revenue:
$771.65M
Net Income/Loss:
$-120.49M
P/E Ratio:
-4.326
EPS:
-3.19
Net Cash Flow:
$-73.76M
1W Performance:
+12.10%
1M Performance:
+24.89%
6M Performance:
-23.59%
1Y Performance:
-13.97%
1-Day Range:
$12.97
$13.83
1-Week Range:
$12.10
$13.83
52-Week Range:
$10.24
$20.73
Orthofix Medical Inc Stock (OFIX) Company Profile
Name
Orthofix Medical Inc
Sector
Industry
Phone
214-937-2000
Address
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
13.80 | 511.06M | 771.65M | -120.49M | -73.76M | -3.19 |
|
ABT
Abbott Laboratories
|
131.02 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.64 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.61 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.08 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.93 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Canaccord Genuity | Buy |
| Nov-08-24 | Upgrade | Stifel | Hold → Buy |
| May-08-24 | Upgrade | ROTH MKM | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Sep-12-23 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-12-23 | Downgrade | Stifel | Buy → Hold |
| Jul-19-23 | Resumed | BTIG Research | Buy |
| Mar-04-22 | Upgrade | Stifel | Hold → Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Oct-29-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Jun-14-17 | Initiated | Ladenburg Thalmann | Buy |
| May-23-17 | Initiated | SunTrust | Buy |
| Jul-10-15 | Initiated | Sidoti | Buy |
| May-09-13 | Downgrade | Mizuho | Buy → Neutral |
| Jan-08-13 | Reiterated | Mizuho | Buy |
| Jun-21-10 | Initiated | Boenning & Scattergood | Outperform |
| Mar-09-10 | Reiterated | Jefferies & Co | Buy |
| Feb-18-10 | Upgrade | Susquehanna Financial | Neutral → Positive |
| Jan-22-10 | Initiated | Jefferies & Co | Buy |
| Nov-03-09 | Upgrade | Wells Fargo | Underperform → Market Perform |
| Jul-31-09 | Reiterated | Jefferies & Co | Buy |
| Jul-31-09 | Upgrade | Thomas Weisel | Market Weight → Overweight |
| May-26-09 | Reiterated | Jefferies & Co | Buy |
| Apr-17-09 | Downgrade | Wachovia | Mkt Perform → Underperform |
| Feb-19-09 | Initiated | Canaccord Adams | Buy |
| Jul-07-08 | Downgrade | Wachovia | Outperform → Mkt Perform |
View All
Orthofix Medical Inc Stock (OFIX) Latest News
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Orthofix Medical Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – OFIX - ACCESS Newswire
Cervical Total Disc Replacement Device Market to Grow at 20.9% - openPR.com
Orthofix Medical: Attractive Valuation Amid Insider Buying - AInvest
Orthofix Medical: Compelling Valuation Supported By Insider Purchases (OFIX) - Seeking Alpha
Orthofix anticipates full-year net sales of $808M–$816M while accelerating U.S. spine distributor transition - MSN
External Fixators Market to Surpass $1.48 Billion by 2033, - openPR.com
Orthofix Medical Inc. (NASDAQ:OFIX) Q2 2025 Earnings Call Transcript - Insider Monkey
Orthofix Q2 2025 net sales up 2.3% to USD 203.1 million - Medical Buyer
Orthofix Medical 2025 Q2 Earnings Losses Narrow by 59.1% - AInvest
Orthofix Reports Second Quarter 2025 Financial Results - BioSpace
Orthofix: Q2 Earnings Snapshot - New Haven Register
Orthofix Medical Inc (OFIX) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... By GuruFocus - Investing.com Canada
Orthofix Medical Inc (OFIX) Q2 2025 Earnings Call Highlights: St - GuruFocus
Orthofix (OFIX) Q2 Revenue Rises 2% - The Motley Fool
Orthofix Q2 2025 slides: Positive free cash flow achieved amid strong U.S. growth - Investing.com
Earnings call transcript: Orthofix beats Q2 2025 forecasts, stock surges - Investing.com
Earnings call transcript: Orthofix beats Q2 2025 forecasts, stock surges By Investing.com - Investing.com India
Orthofix stock rises on Street-beating Q2 - MassDevice
Orthofix Q2 2025: Navigating Key Contradictions in Spine Transition, AccelStim Launch, and Pricing Strategy - AInvest
Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Orthofix Medical Q2 Financial Results: Loss and Revenue GrowthNews and Statistics - IndexBox
Medtech Orthofix Medical Q2's sales growth beat expectations - MarketScreener
Orthofix Reports Q2 2025 Financial Results and Growth - TipRanks
Orthofix Medical Inc. SEC 10-Q Report - TradingView
Orthofix Medical Inc. Reaches Critical Trendline SupportSwing Trading Entry Signals Suggest Opportunity Zone - metal.it
Is it the right time to buy Orthofix Medical Inc. stockFree Stock Market Real-Time Monitoring - Jammu Links News
What are the technical indicators suggesting about Orthofix Medical Inc.Achieve rapid portfolio appreciation today - Jammu Links News
Is Orthofix Medical Inc. stock overvalued or undervaluedSkyrocketing returns - Jammu Links News
What institutional investors are buying Orthofix Medical Inc. stockHigh-yield market plays - Jammu Links News
What is the dividend policy of Orthofix Medical Inc. stockStay informed with expert market forecasts - Jammu Links News
Orthofix Medical Inc. Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News
How volatile is Orthofix Medical Inc. stock compared to the marketCapitalize on emerging investment opportunities - Jammu Links News
Is Orthofix Medical Inc. a growth stock or a value stockAccelerated wealth expansion - Jammu Links News
When is Orthofix Medical Inc. stock expected to show significant growthCapitalize on proven investment strategies - Jammu Links News
What are Orthofix Medical Inc. company’s key revenue driversFree Stock Movement Tracking - Jammu Links News
How does Orthofix Medical Inc. generate profit in a changing economyTurbocharged investment results - Jammu Links News
What analysts say about Orthofix Medical Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What are analysts’ price targets for Orthofix Medical Inc. in the next 12 monthsMassive stock growth - Jammu Links News
Why is Orthofix Medical Inc. stock attracting strong analyst attentionHigh-performance stocks for savvy investors - Jammu Links News
Press Release: Orthofix to Report Second Quarter 2025 Financial Results - 富途牛牛
Published on: 2025-08-01 21:25:19 - metal.it
Orthofix Medical's High Institutional Ownership Indicates Market Sensitivity - AInvest
With 53% institutional ownership, Orthofix Medical Inc. (NASDAQ:OFIX) is a favorite amongst the big guns - Yahoo Finance
Is Orthofix Medical Inc. stock bottoming outReal Profit Trade Plan Suggestions Shared Widely - metal.it
Orthofix Medical Inc Stock (OFIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orthofix Medical Inc Stock (OFIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McPherron Aviva | Pres, Global Ops & Qual |
Jun 18 '25 |
Sale |
10.51 |
3,728 |
39,181 |
46,322 |
| REINHARDT MAX | President, Global Spine |
Jun 11 '25 |
Sale |
11.64 |
1,643 |
19,125 |
27,481 |
| Bazaar Alan Lee | Director |
Jun 04 '25 |
Buy |
10.92 |
2,250 |
24,570 |
30,983 |
| Calafiore Massimo | President & CEO |
May 09 '25 |
Buy |
12.54 |
10,000 |
125,400 |
234,603 |
| Bazaar Alan Lee | Director |
May 12 '25 |
Buy |
12.59 |
2,000 |
25,172 |
28,733 |
| Bazaar Alan Lee | Director |
May 09 '25 |
Buy |
12.62 |
1,990 |
25,120 |
26,733 |
| Engine Capital Management, LP | 10% Owner |
May 07 '25 |
Buy |
12.31 |
100,000 |
1,231,000 |
3,544,807 |
| Cedron Jorge Andres | CLO |
Apr 16 '25 |
Sale |
13.31 |
3,816 |
50,791 |
42,500 |
| Gillespie Geoffrey C | CAO |
Apr 02 '25 |
Sale |
15.74 |
76 |
1,196 |
42,445 |
| Vitale Lucas | CP&BOO |
Mar 18 '25 |
Sale |
16.60 |
4,287 |
71,164 |
135,317 |
1.57%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):